A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)
Clinical trial NCT00932074 · COMPLETED
Trial details
- NCT number
- NCT00932074
- Sponsor
- Kaken Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-06-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.